University at Buffalo, The State University of New York — Buffalo, New York

University at Buffalo, The State University of New York is a clinical research site located in Buffalo, New York, United States 14260.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

University at Buffalo, The State University of New York has participated in 6 clinical trials.

Therapeutic areas: Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive, Atrial Fibrillation.

Sponsors: MediciNova, Boehringer Ingelheim, Medtronic Cardiac Rhythm and Heart Failure.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University at Buffalo, The State University of New York?

University at Buffalo, The State University of New York has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University at Buffalo, The State University of New York conducted?

University at Buffalo, The State University of New York has 6 clinical trials on record. Their work covers Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive, Atrial Fibrillation.

Is University at Buffalo, The State University of New York accredited by Crixeo Health?

University at Buffalo, The State University of New York has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University at Buffalo, The State University of New York?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.